e-learning
resources
Vienna 2012
Monday, 03.09.2012
Tuberculosis: clinical findings II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anti-tuberculosis therapy as a reason for ejaculatory disorders
E. Kulchavenya, E. Brizhatyuk, D. Kholtobin, A. Osadchyi (Novosibirsk, Russian Federation)
Source:
Annual Congress 2012 - Tuberculosis: clinical findings II
Session:
Tuberculosis: clinical findings II
Session type:
Thematic Poster Session
Number:
2606
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Kulchavenya, E. Brizhatyuk, D. Kholtobin, A. Osadchyi (Novosibirsk, Russian Federation). Anti-tuberculosis therapy as a reason for ejaculatory disorders. Eur Respir J 2012; 40: Suppl. 56, 2606
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Noncompliance on antituberculosis treatment and the psychological profile
Source: Eur Respir J 2001; 18: Suppl. 33, 467s
Year: 2001
Problems of treatment of TB patients suffering from alcohol and drugs addiction
Source: Eur Respir J 2002; 20: Suppl. 38, 369s
Year: 2002
The effectiveness of TB treatment in patients with gastrointestinal tract disorders, depending on the way of administration of anti-TB drugs
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
The side-effects of TB therapy: myth and reality
Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties
Year: 2005
DOTS-Plus treatment of MDR-TB patients with psychiatric disorders
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Withdrawal symptoms in psychiatric patients treated with varenicline
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008
Second-line injectables: are they essential to treat MDR/XDR-TB cases?
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008
Influence of psychiatric disorders in patients treated with Varenicline.
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017
Drug-induced sleep endoscopy predictors for oral appliance treatment outcome
Source: Annual Congress 2013 –Back to basics: the upper airway and physiology in sleep disordered breathing
Year: 2013
The efficacy and side-effects of varenicline in patients with pneumologic diseases
Source: Annual Congress 2009 - Smoking cessation
Year: 2009
Use of relievers in patients with severe asthma on biologic therapy –a multidisciplinary approach
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Year: 2020
Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Can we really relieve the withdrawal syndrome with pharmacotherapy in smoking cessation?
Source: Annual Congress 2012 - Tobacco cessation
Year: 2012
First-line therapy
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Bronchial asthma as neurogenic inflammatory and paroxysmal disease – efficacy of antiepileptic drug diphenine in asthma therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 316s
Year: 2006
Is surgical treatment a motivator factor for smoking cessation? Experience in an anticancer hospital
Source: International Congress 2015 – Smoking cessation
Year: 2015
Self-care behavior for medications use and treatment outcome in elderly with asthma
Source: Annual Congress 2010 - Dysfunctional breathing, asthma and respiratory physiotherapy problems
Year: 2010
Paradox radiologic progression despite appropriate antituberculosis therapy
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011
Reasons for hepatotoxic reactions to chemotherapeutic agents and possibilities of their prevention in adolescents with tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 468s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept